Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

Fade to black!

Zohaib Yousaf, Muhammad Bilal Jamshaid, Dawlat Khan, Khaled A. Murshed, Huma Munir
Breathe 2020 16: 200221; DOI: 10.1183/20734735.0221-2020
Zohaib Yousaf
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zohaib Yousaf
  • For correspondence: zohaib.yousaf@gmail.com
Muhammad Bilal Jamshaid
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dawlat Khan
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khaled A. Murshed
1Hamad Medical Corporation, Doha, Qatar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huma Munir
2College of Physicians and Surgeons Pakistan, Karachi, Pakistan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Black pleural effusion is a rare entity and may be a diagnostic dilemma. This interactive case discusses the various steps involved to reach the diagnosis. https://bit.ly/3dFJPTS

A 71-year-old man presented to the emergency room with chest pain, dry cough, shortness of breath and night sweats for 10 days. He had no fever, flu-like symptoms, sputum production or haemoptysis. There was no history of recent travel or sick contacts. A general review of systems was remarkable for subjective weight loss and malaise. He was an active smoker with a 100 pack-years smoking history and a past medical history of rectal squamous cell carcinoma (SCC). His cancer was treated with chemoradiotherapy and had been in remission for 8 years before the presentation. He was also known to have COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) category B, well-controlled, with no recent hospitalisations or exacerbations over the past year.

Upon initial examination, arterial blood pressure was 123/75 mmHg, heart rate was 81 beats per min, respiratory rate was 24 breaths per min, and oxygen saturation was 93% on room air. Arterial blood gases showed partial oxygen pressure 73 mmHg, carbon dioxide tension 45 mmHg and pH 7.43. There were decreased breath sounds on the right side, up to the upper lung zone with dull percussion note and reduced tactile vocal fremitus on chest examination. The physical examination was unremarkable otherwise. The patient had a chest radiograph, which showed a right-sided pleural effusion (figure 1).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Chest radiograph depicting right-sided pleural effusion.

Task 1

What is the most likely diagnosis?

  • a) Community-acquired pneumonia (CAP)

  • b) Malignancy

  • c) Tuberculosis (TB)

  • d) Pulmonary embolism

Answer 1

b.

The most likely diagnosis is malignant pleural effusion due to significant smoking history and prior history of malignancy. CAP and pulmonary TB are differentials. The patient received intravenous antibiotics for possible CAP.

Task 2

What is the most appropriate investigation to undertake next?

  • a) Thoracentesis

  • b) Order a computed tomography (CT) scan

  • c) Perform bronchoscopy

  • d) Quantiferon Gold for TB

Answer 2

a.

A diagnostic thoracentesis is needed to establish appropriate diagnosis. Under ultrasound guidance, a diagnostic and therapeutic thoracentesis yielded 1200mL of fluid. Shortness of breath and tachypnoea improved post-procedure.

The fluid analysis results showed straw-coloured lymphocytic, exudative effusion, a negative Gram stain, and malignant cells, consistent with malignant pleural effusion (table 1). The pleural fluid analysis was not suggestive of complicated parapneumonic effusion or empyema.

View this table:
  • View inline
  • View popup
Table 1

Pleural fluid analysis

On day 2 of admission, the patient developed worsening shortness of breath and desaturation. A follow-up examination revealed tracheal deviation to the left side, with decreased vocal fremitus and reduced breath sounds on the right side.

Task 3

What is expected on a repeat chest radiograph?

  • a) Reaccumulating pleural effusion

  • b) New consolidation

  • c) Lung collapse

  • d) Pneumothorax

Answer 3

d.

A repeat chest radiograph revealed iatrogenic pneumothorax on the side of the pleural effusion (figure 2).

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2

Chest radiograph depicting right-sided pneumothorax.

Task 4

What should be the next step in the management of the patient?

  • a) Oxygen supplementation and observation

  • b) Needle aspiration

  • c) Chest tube insertion

  • d) High-flow nasal oxygen

Answer 4

c.

The patient has a >2 cm iatrogenic pneumothorax and is symptomatic. Hence a chest tube was inserted and connected to the underwater seal (figure 3).

Figure 3
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3

Chest radiograph showing a right-sided chest tube and partial lung re-expansion.

The patient's shortness of breath progressed despite chest tube insertion. The chest tube was functioning appropriately, as evidenced by swinging fluid levels and bubbling. CT of the chest was performed (figure 4).

Figure 4
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4

Chest CT.

Task 5

Can you identify the finding on the chest CT image (figure 4)?

  • a) Pneumothorax

  • b) Apical bleb

  • c) Sub-pleural nodules

  • d) All of the above

Answer 5

d.

The right lung shows a sizeable pneumothorax, apical subpleural blebs and subpleural nodules. Other cuts of CT revealed multiple spiculated nodules throughout both lung fields.

Task 6

Considering the persistent air-leak, what is the most appropriate next step in management?

  • a) Perform bronchoscopy

  • b) Pleurodesis

  • c) Thoracoscopy

  • d) Bilateral chest tube insertion

Answer 6

c.

The patient underwent right-sided video-assisted thoracoscopy. There was an upper lobe scar with surrounding nodules and continuous air leak. The thoracic surgery team performed an upper lobe wedge resection to fix the air leak and inserted a chest tube connected to an underwater seal. The colour of the fluid draining from the chest tube noted immediately post chest tube insertion was black (figure 5).

Figure 5
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5

Black-coloured pleural fluid draining from the chest tube.

Task 7

What is the most common cause of this finding?

  • a) Crack cocaine use

  • b) Malignancy

  • c) Fungal infection

  • d) Pancreatic pseudocyst rupture with pancreaticoplural fistula

Answer 7

b.

The most common cause of the black pleural effusion is malignancy. The pleural fluid analysis was consistent with empyema secondary to Pseudomonas aeruginosa and Klebsiella pneumoniae (table 1). Multiple invasive procedures, including a thoracocentesis and chest tube insertion performed before thoracoscopy on a frail, elderly patient with underlying malignancy, could have led to an iatrogenic empyema. Pyomelanin is a brown/black extracellular pigment produced by Pseudomonas; however, it does not cause black discolouration of body fluids.

The patient also had neutrophilic leukocytosis, a raised C-reative protein (324 mg·L−1), and high procalcitonin (38.2 ng·mL−1). He received piperacillin/tazobactam with a working diagnosis of empyema. Over the next 8 weeks, 8 L of pleural fluid was drained. Although the pleural fluid haematocrit was not measured, there was no drop in haemoglobin with massive fluid removal. Moreover, the fluid was free-flowing without any clots. The persisting dark colour of the fluid despite a decrease in RBC content over time without a haemoglobin drop indicates the absence of haemodynamically significant bleeding. The possibility of the black colour being secondary to haemolysis cannot be excluded entirely; however, the fact that the fluid colour turned to black immediately post-thoracoscopy without an initial red colour, which is more typical of a haemothorax, makes acute bleeding less likely as a cause. The other possibility is of bilothorax, which is usually reported secondary to a pancreaticopleural fistula. The absence of ascites and right-sided effusion makes that less likely.

Reported causes of black pleural fluid associated with malignancy are either due to pigment production by malignant cells (e.g. melanoma) or haemolysis. The black pleural effusion associated with most adenocarcinoma cases has been attributed to haemolysis. The authors believe that the absence of black colour from the initial pleural fluid sample, and then the appearance of this colour post-thoracoscopy, may be suggestive of the colour being attributed to the surgical intervention. However, to the best of our knowledge, such an association is not reported in the literature.

The surgical pathology report from the wedge resection showed infiltration of the lung by poorly differentiated malignant cells forming solid sheets. The tumour cells were pleomorphic with abundant eosinophilic cytoplasm, along with frequent mitotic figures and atypical forms. Immunohistochemistry was negative for P-40 and P-63, which are the markers for SCC. This immunoreactivity excluded the possibility of recurrence of the rectal SCC. The tumour cells’ reactivity for epithelial-specific antigen (MOC-31) and BER-EP4 confirmed the epithelial origin of the tumour. Based on negative lung adenocarcinoma markers, thyroid transcription factor 1 (TTF-1) and napsin-A, a lung primary was less likely. TTF-1 immunoreactivity is highly sensitive and specific in determining pulmonary versus extrapulmonary origin of adenocarcinoma [1]. In extrapulmonary adenocarcinomas (except thyroid) is so low (1%) that the negativity for TTF-1 may be interpreted as definitive evidence that the tumour is a primary from an extrapulmonary source. The cells were immunopositive for cytokeratin (CK)-7 expression and immunonegative for CK-20 expression (figure 6). A definitive conclusion on the origin of the tumour based entirely on the immuno-staining is challenging due to the lack of additional markers of pancreatic and hepatobiliary origin.

Figure 6
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6

Histopathology slides. a) Poorly differentiated tumour arranged in solid sheets (haematoxylin and eosin stain, magnification x100). b) Highly pleomorphic tumour cells with brisk mitotic activity (haematoxylin and eosin stain x400). c) Immunoreactive for CK-7 (immunohistochemistry x100). d) Negative for CK-20 (immunohistochemistry x100). e) Negative for TTF-1 (immunohistochemistry x200). f) Negative for napsin-A (immunohistochemistry x100).

CT of the chest, abdomen and pelvis with contrast showed a dilated common bile duct measuring 16 mm with associated dilated intrahepatic biliary radicals. CK-7 positivity and CK-20 negativity in biliary tract carcinomas are associated with intrahepatic bile duct carcinomas. Tumour markers showed normal alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA), but a raised carbohydrate antigen 19-9 (CA19-9) (table 2). The serum alkaline phosphatase, total bilirubin and aspartate aminotransferase were also elevated. The patient's age, sex, tumour marker profile, immunohistochemical profile, liver function profile, and imaging data fit the possibility of metastasis from a hepatobiliary origin, likely intrahepatic bile duct carcinoma [2–5].

View this table:
  • View inline
  • View popup
Table 2

Tumour markers

A multidisciplinary team meeting between the primary team, pulmonology, cardiothoracic surgery, oncology, onco-radiology and histopathology was conducted. The general condition of the patient made him unfit for further malignancy workup or chemotherapy. He received palliative care from thereon. He later passed away due to the progression of the disease.

Discussion

The aetiologies of pleural effusion are varied and range from infection to malignancy and autoimmunity to drugs of abuse [6, 7]. Analysis of pleural fluid is essential to the diagnosis of underlying aetiology. The pleural fluid colour may vary from clear or straw-coloured to blood-tinged or frankly bloody [8]. It is incredibly unusual to have black coloured pleural effusion. The authors reviewed the literature on Medline, PubMed, Embase and Google scholar. Key terms used were (“black” and ((“pleura” or pleural”)) and “effusion”). The search duration was from 1950 to June 26, 2020. The search identified 25 reported cases of black pleural effusion (table 3).

View this table:
  • View inline
  • View popup
Table 3

Previously reported cases of black pleural effusion

There are 11 reported cases of black pleural fluid secondary to malignancy. What makes this case unique is the immunostaining being negative for lung markers and melanoma. Hence, it is the first reported black pleural effusion case thought to be secondary to hepatobiliary malignancy.

Footnotes

  • Conflict of interest: Z. Yousaf has nothing to disclose.

  • Conflict of interest: M.B. Jamshaid has nothing to disclose.

  • Conflict of interest: D. Khan has nothing to disclose.

  • Conflict of interest: K.A. Murshed has nothing to disclose.

  • Conflict of interest: H. Munir has nothing to disclose.

  • Received May 11, 2020.
  • Accepted October 13, 2020.
  • Copyright ©ERS 2021
http://creativecommons.org/licenses/by-nc/4.0/

Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Moldvay J,
    2. Jackel M,
    3. Bogos K, et al.
    The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas. Pathol Oncol Res 2004; 10: 85–88. doi:10.1007/BF02893461
    OpenUrlCrossRefPubMed
  2. ↵
    1. Everhart J,
    2. Ruhl C
    . Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas. Gastroenterology 2009; 136: 1134–1144. doi:10.1053/j.gastro.2009.02.038
    OpenUrlCrossRefPubMed
    1. Tyson G,
    2. El-Serag H
    . Risk factors for cholangiocarcinoma. Hepatology 2011; 54: 173–184. doi:10.1002/hep.24351
    OpenUrlCrossRefPubMed
    1. Chen Z,
    2. Lin F
    . Application of immunohistochemistry in gastrointestinal and liver neoplasms: new markers and evolving practice. Arch Pathol Lab Med 2015; 139: 14–23. doi:10.5858/arpa.2014-0153-RA
    OpenUrl
  3. ↵
    1. Cabibi D,
    2. Licata A,
    3. Barresi E, et al.
    Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract. Pathol Res Pract 2003; 199: 65–70. doi:10.1078/0344-0338-00356
    OpenUrlCrossRefPubMed
  4. ↵
    1. Chhabra A,
    2. Mukherjee V,
    3. Chowdhary M, et al.
    Black pleural effusion: a unique presentation of metastatic melanoma. Case report. Oncol 2015; 8: 222–225.
    OpenUrl
  5. ↵
    1. Mohan KM,
    2. Gowrinath K
    . Unusual thoracic manifestation of metastatic malignant melanoma. Lung India 2010; 27: 96. doi:10.4103/0970-2113.63615
    OpenUrlPubMed
  6. ↵
    1. Patel G,
    2. Saxena A,
    3. Khangarot S, et al.
    Recurrence of malignant melanoma presenting as black-colored pyopneumothorax: a rare entity. Ann Saudi Med 2017; 37: 469–471. doi:10.5144/0256-4947.2017.469
    OpenUrl
    1. Mishe'el S,
    2. Ziv M,
    3. Bisharat N
    . Black urine and black pleural fluid: a distinctive presentation of metastatic melanoma. Eur J Case Rep Intern Med 2016; 3: 000416. doi:10.12890/2016_000416
    OpenUrl
    1. Sumalani KK,
    2. Rehman U,
    3. Akhter N, et al.
    Black pleural effusion: an unusual presentation of metastatic melanoma diagnosed by medical thoracoscopy. Respirol Case Rep 2019; 7: e00490.
    OpenUrl
    1. Liao W-C,
    2. Chen C-H,
    3. Tu C-Y
    . Black pleural effusion in melanoma. CMAJ Can Med Assoc J 2010; 182: E314. doi:10.1503/cmaj.091312
    OpenUrl
    1. Guo F,
    2. Wu J,
    3. Peng Y, et al.
    Black pleural effusion due to pancreatic pseudocyst. Medicine (Baltimore) 2017; 96: e9043. doi:10.1097/MD.0000000000009043
    OpenUrl
    1. Ishigaki S,
    2. Kuwae M,
    3. Ishii M, et al.
    Black pleural effusion caused by pancreatic pseudocyst rupture. Clin Case Rep 2019; 7: 385–386. doi:10.1002/ccr3.1994
    OpenUrl
    1. Kaur D,
    2. Singh G,
    3. Banas E, et al.
    Black pleural effusion in an alcoholic: make the connection. Chest 2014; 146: 467A. doi:10.1378/chest.1992362
    OpenUrl
    1. Huang T-Y,
    2. Tsai M-J
    . Gastrointestinal: Black pleural effusion induced by pancreaticopleural fistula. J Gastroenterol Hepatol 2013; 28: 1798–1798. doi:10.1111/jgh.12409
    OpenUrl
    1. Koide T,
    2. Saraya T,
    3. Nakajima A, et al.
    A 54-year-old man with an uncommon cause of left pleural effusion. Chest 2012; 141: 560–563. doi:10.1378/chest.11-1493
    OpenUrlCrossRefPubMed
    1. Mookherjee S,
    2. Minkoff N,
    3. Shah V, et al.
    A curious case of a reaccumulating black colored pleural effusion!. Chest 2014; 146: 482A. doi:10.1378/chest.1992338
    OpenUrl
    1. Lai C-C,
    2. Liaw S-J,
    3. Hsiao Y-C, et al.
    Empyema thoracis due to Rhizopus oryzae in an allogenic bone marrow transplant recipient. Med Mycol 2006; 44: 75–78. doi:10.1080/13693780500148392
    OpenUrlCrossRefPubMed
    1. Metzger JB,
    2. Garagusi VF,
    3. Kerwin DM
    . Pulmonary oxalosis caused by Aspergillus niger. Am Rev Respir Dis 1984; 129: 501–502.
    OpenUrlPubMed
    1. Koff A,
    2. Malinis M
    . Chest pain and a cavitary lung mass in a woman with diabetes. JAMA 2020; 323: 2421–2422. doi:10.1001/jama.2020.4111
    OpenUrl
    1. Jayakrishnan B,
    2. Dildar B,
    3. Rizavi DM, et al.
    Black pleural effusion. Lancet 2015; 386: e7. doi:10.1016/S0140-6736(14)62003-1
    OpenUrl
    1. Thampy E,
    2. Cherian SV
    . Black pleural effusion. QJM Int J Med 2016; 109: 761–761. doi:10.1093/qjmed/hcw150
    OpenUrl
    1. Fernandes V,
    2. Alfaro TM,
    3. Cruz C, et al.
    Black pleural effusion as the presenting feature of lung cancer. Eur Respir J 2018; 52: Suppl. 62, PA4113.
    OpenUrlCrossRef
    1. Rojas-Solano JR,
    2. Light RW,
    3. Brenes-Dittel A
    . [Black pleural fluid]. Arch Bronconeumol 2009; 45: 103–104.
    OpenUrlCrossRefPubMed
    1. Singh B,
    2. Greenebaum E,
    3. Cole R
    . Carbon-laden macrophages in pleural fluid of crack smokers. Diagn Cytopathol 1995; 13: 316–319. doi:10.1002/dc.2840130408
    OpenUrlCrossRefPubMed
    1. Mitra S,
    2. Sarma MK,
    3. Das AK
    . Curious case of a black pleural effusion: Mediastinal teratoma presenting as massive pleural effusion. Lung India Off Organ Indian Chest Soc 2018; 35: 87–89. doi:10.4103/lungindia.lungindia_253_17
    OpenUrl
    1. Jacob AG,
    2. George AM,
    3. John T
    . Rheumatoid pleurisy presenting as black pleural effusion. Chest 2014; 146: 471A. doi:10.1378/chest.1983626
    OpenUrl
    1. Justiniani FR,
    2. Hippalgaonkar R,
    3. Martinez LO
    . Charcoal-containing empyema complicating treatment for overdose. Chest 1985; 87: 404–405. doi:10.1378/chest.87.3.404
    OpenUrlCrossRefPubMed
    1. Hirsh J,
    2. Erb CT,
    3. Fares WH
    . Welcome to the dark side: a case of black pleural fluid. Am J Respir Crit Care Med 2018; 197: Suppl., A3217.
    OpenUrl
PreviousNext
Back to top
Vol 16 Issue 4 Table of Contents
Breathe: 16 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Fade to black!
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Fade to black!
Zohaib Yousaf, Muhammad Bilal Jamshaid, Dawlat Khan, Khaled A. Murshed, Huma Munir
Breathe Dec 2020, 16 (4) 200221; DOI: 10.1183/20734735.0221-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Fade to black!
Zohaib Yousaf, Muhammad Bilal Jamshaid, Dawlat Khan, Khaled A. Murshed, Huma Munir
Breathe Dec 2020, 16 (4) 200221; DOI: 10.1183/20734735.0221-2020
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory clinical practice
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Expert opinion

  • Lung cancer screening by volume CT
  • In pursuit of the primary
  • A rare complication in a case of nonsmall cell lung carcinoma
Show more Expert opinion

Case report

  • Bilateral mediastinal lymphadenopathy with cough and shortness of breath
  • Recurrent bilateral lung infiltrates in a patient with UC
  • A pregnant woman with severe dyspnoea
Show more Case report

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society